Testing for heparin-induced thrombocytopenia antibodies.
about
Fondaparinux and the management of heparin-induced thrombocytopenia: the journey continues.Unfractionated heparin for hemodialysis: still the best option.Fondaparinux: does it cause HIT? Can it treat HIT?Usefulness of anti-PF4/heparin antibody test for intensive care unit patients with thrombocytopenia.Systematic review on heparin-induced thrombocytopenia in children: a call to action.Protamine-induced immune thrombocytopenia.Recent advances in the diagnosis and treatment of heparin-induced thrombocytopenia.The clinical significance and risk factors of anti-platelet factor 4/heparin antibody on maintenance hemodialysis patients: a two-year prospective follow-up.Thromboprophylaxis patterns and determinants in critically ill patients: a multicenter auditArgatroban versus Lepirudin in critically ill patients (ALicia): a randomized controlled trialPitfalls in the diagnosis of heparin-Induced thrombocytopenia: A 6-year experience from a reference laboratory.Distinguishing between anti-platelet factor 4/heparin antibodies that can and cannot cause heparin-induced thrombocytopenia.Bivalirudin for Alternative Anticoagulation in Extracorporeal Membrane Oxygenation: A Systematic Review.Inappropriate documentation of heparin allergy in the medical record because of misdiagnosis of heparin-induced thrombocytopenia: frequency and consequences.Clinical effectiveness of a Bayesian algorithm for the diagnosis and management of heparin-induced thrombocytopenia.Development of a high-yield expression and purification system for platelet factor 4.Acquired Thrombophilia.
P2860
Q33386145-6B44FE80-889D-4FDD-A1C8-502FABD1E12FQ33392592-4B13BC4B-A390-4945-8B4A-06703B9E9F38Q33392864-9C40EE37-33F8-4C89-A069-01DF9397C24FQ33400605-8438A118-4CBB-467B-ABD4-3A19BBF04CB5Q33405494-611B84C3-023D-4D5D-A479-70CAEA5C41D5Q33405699-3705DA90-8BE4-4450-8851-CBBCD0B3E8BDQ33407198-1C4B1081-7951-42E4-8998-42D51E4F614CQ33407497-F11A6DA6-20DF-42C5-A89B-C1D5C22AB81AQ33414888-3EC170B3-2737-4BC2-9156-EDA9C700E2EBQ33418376-E1D6CEBD-FF93-4152-81E5-A2811F7CF0B1Q33421456-FFA07C89-7F7C-4814-8DB2-0721E83C7440Q33425288-BED42DD6-A3C0-4EAB-BBBD-D4915BC120D9Q33433514-DEF354CD-58E0-4F52-BB60-D4ED6CFA20A4Q33437858-31A0DD25-8A98-46A8-8987-CB9B3445893BQ33442746-8079EBFA-7B84-428A-8D6C-8095F6DB8643Q47367479-440851AA-F14E-4574-98C5-5CE1A9ED0833Q51846266-41C08C1C-5B7E-4AB8-A078-E69F76CBF3AE
P2860
Testing for heparin-induced thrombocytopenia antibodies.
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Testing for heparin-induced thrombocytopenia antibodies.
@ast
Testing for heparin-induced thrombocytopenia antibodies.
@en
type
label
Testing for heparin-induced thrombocytopenia antibodies.
@ast
Testing for heparin-induced thrombocytopenia antibodies.
@en
prefLabel
Testing for heparin-induced thrombocytopenia antibodies.
@ast
Testing for heparin-induced thrombocytopenia antibodies.
@en
P1476
Testing for heparin-induced thrombocytopenia antibodies.
@en
P2093
Jo-Ann I Sheppard
P304
P356
10.1016/J.TMRV.2006.05.001
P577
2006-10-01T00:00:00Z